- Home
- BCRX vs UMH Comparison
BCRX vs UMH Comparison
Compare BCRX & UMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- UMH
- Stock Information
- Founded
- BCRX 1986
- UMH 1968
- Country
- BCRX United States
- UMH United States
- Employees
- BCRX N/A
- UMH N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- UMH Real Estate Investment Trusts
- Sector
- BCRX Health Care
- UMH Real Estate
- Exchange
- BCRX Nasdaq
- UMH Nasdaq
- Market Cap
- BCRX 1.7B
- UMH 1.4B
- IPO Year
- BCRX 1994
- UMH N/A
- Fundamental
- Price
- BCRX $9.97
- UMH $17.28
- Analyst Decision
- BCRX Buy
- UMH Strong Buy
- Analyst Count
- BCRX 8
- UMH 4
- Target Price
- BCRX $16.75
- UMH $21.00
- AVG Volume (30 Days)
- BCRX 5.9M
- UMH 363.5K
- Earning Date
- BCRX 05-05-2025
- UMH 05-01-2025
- Dividend Yield
- BCRX N/A
- UMH 5.20%
- EPS Growth
- BCRX N/A
- UMH N/A
- EPS
- BCRX N/A
- UMH 0.10
- Revenue
- BCRX $503,485,000.00
- UMH $243,777,000.00
- Revenue This Year
- BCRX $27.64
- UMH $10.24
- Revenue Next Year
- BCRX $13.42
- UMH $8.52
- P/E Ratio
- BCRX N/A
- UMH $166.76
- Revenue Growth
- BCRX 41.67
- UMH 8.17
- 52 Week Low
- BCRX $5.06
- UMH $14.73
- 52 Week High
- BCRX $11.11
- UMH $20.64
- Technical
- Relative Strength Index (RSI)
- BCRX 65.89
- UMH 44.53
- Support Level
- BCRX $9.83
- UMH $17.01
- Resistance Level
- BCRX $11.11
- UMH $17.49
- Average True Range (ATR)
- BCRX 0.51
- UMH 0.36
- MACD
- BCRX 0.20
- UMH 0.01
- Stochastic Oscillator
- BCRX 68.33
- UMH 28.13
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About UMH UMH Properties Inc.
UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.